Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06636682
Title FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Cellvax Therapeutics Inc
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.